本页面由Tiger Trade Technology Pte. Ltd.提供服务

Pacific Biosciences of Californi

2.10
-0.2300-9.87%
盘前:2.100.0001+0.00%04:29 EDT
成交量:1,208.39万
成交额:2,540.72万
市值:6.52亿
市盈率:-4.87
高:2.29
开:2.24
低:2.01
收:2.33
52周最高:3.44
52周最低:1.07
股本:3.10亿
流通股本:3.02亿
量比:0.46
换手率:4.00%
股息:- -
股息率:- -
每股收益(TTM):-0.4310
每股收益(LYR):-1.8215
净资产收益率:-929.32%
总资产收益率:-14.07%
市净率:-19.63
市盈率(LYR):-1.15

数据加载中...

2024/02/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/15

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/05

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/30

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/10

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/08

重要事件披露

Form 8-K - Current report
2023/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/11

重要事件披露

Form 8-K - Current report
2023/11/03

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/31

重要事件披露

Form 8-K - Current report
2023/10/27

重要事件披露

Form 8-K/A - Current report: [Amend]
2023/10/16

重要事件披露

Form 8-K - Current report
2023/09/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/23

重要事件披露

Form 8-K/A - Current report: [Amend]
2023/09/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities